Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT
Language English Country England, Great Britain Media print-electronic
Document type Journal Article
PubMed
29808926
DOI
10.1111/bjh.15407
Knihovny.cz E-resources
- Keywords
- JAK inhibitors, allogeneic stem cell transplant, fibrosis, mylelofibrosis, relapse,
- MeSH
- Survival Analysis MeSH
- Adult MeSH
- Drug Therapy MeSH
- Transplantation, Homologous MeSH
- Middle Aged MeSH
- Humans MeSH
- Disease Management MeSH
- Primary Myelofibrosis mortality therapy MeSH
- Recurrence MeSH
- Retrospective Studies MeSH
- Lymphocyte Transfusion MeSH
- Hematopoietic Stem Cell Transplantation methods MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Allogeneic Haematopoietic Stem Cell Transplant (allo-HSCT) remains the only curative approach for Myelofibrosis (MF). Scarce information exists in the literature on the outcome and, indeed, management of those MF patients who relapse following transplant. We hereby report on the management and outcome of 202 patients who relapsed post allo-HSCT for MF.
CHU de Lille LIRIC INSERM U995 Universite de Lille Lille France
Clinic for Cancer Surgery and Transplantation Oslo University Hospital Rikshospitalet Norway
Comprehensive Cancer Centre Division of Haematology King's College London
Department of Haematology and Oncology University of Regensburg Regensburg Germany
Department of Haematology Hopital d`Enfants Nancy France
Department of Haematology Karolinska University Hospital Stockholm Sweden
Department of Haematology Radboud University Medical Centre Nijmegen the Netherlands
Department of Haematology University of Liege Liege Belgium
Division of Haematology Geneva University Hospitals Geneva Switzerland
EBMT Data Office University Medical Centre Leiden the Netherlands
Erasmus MC Cancer Institute University Medical Centre Rotterdam the Netherlands
Hammersmith Hospital NHS Foundation Trust London United Kingdom
Institute of Haematology and Blood Transfusion Prague Czech Republic
Ospedale San Martino Genova Italy
Service d'hématologie clinique Adulte et pédiatrie CHU ESTAING Clermont France
Service d'Hématologie Greffe Hôpital Saint Louis Assistance Publique Hôpitaux de Paris Paris France
Stem Cell Transplant Unit Turku University Hospital Turku Finland
University Hospital Eppendorf Hamburg Germany
References provided by Crossref.org
